Company Performance - iRhythm Technologies reported quarterly earnings of 0.01pershare,exceedingtheZacksConsensusEstimateofalossof0.30 per share, and showing improvement from a loss of 1.26pershareayearago,resultinginanearningssurpriseof103.33164.33 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 4.19% and increasing from year-ago revenues of 132.51million[2]−Overthelastfourquarters,iRhythmTechnologieshassurpassedconsensusEPSestimatestwotimesandtoppedconsensusrevenueestimatesfourtimes[2]StockPerformance−iRhythmTechnologiesshareshaveincreasedapproximately25.40.65 on revenues of 154.31million,andforthecurrentfiscalyear,itis−1.98 on revenues of $679.24 million [7] Industry Outlook - The Medical Info Systems industry, to which iRhythm Technologies belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5][6]